the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Sep 4, 20348.0ypatentRyaltris(mometasone furoate + olopatadine hydrochloride)Hikma Pharmaceuticals USA Inc
- Nov 21, 20348.2ypatentDEFERASIROXDEFERASIROXReddy US Therapeutics Inc
- Jan 30, 20358.4ypatentVasostrictvasopressinPar Pharmaceutical Inc
- Feb 25, 20358.5ypatentBrynovinsitagliptinRevio Therapeutics LLP
- Feb 26, 20358.5ypatentNOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEInforlife SA
- Feb 27, 20358.5ypatentBafiertammonomethyl fumarateCycle Pharmaceuticals Ltd
- Mar 13, 20358.5ypatentVancomycin Hydrochloridevancomycin hydrochlorideSamson Medical Technologies LLC
- Mar 26, 20358.5ypatentPemfexypemetrexed [INN]Eagle Pharmaceuticals Inc
- Apr 21, 20358.6ypatenthydrogen peroxideKortuc Japan LLC
- May 29, 20358.7ypatentISOTRETINOINISOTRETINOINAmneal Pharmaceuticals of New York LLC
- Jun 26, 20358.8ypatentCyclophosphamidecyclophosphamide [INN]Long Grove Pharmaceuticals LLC
- Jul 9, 20358.8ypatentToprol-XLmetoprolol succinateMelinta Therapeutics LLC
- Oct 19, 20359.1ypatentVARENICLINE TARTRATEVARENICLINE TARTRATEOyster Point Pharma Inc
- Nov 6, 20359.1ypatentLisinoprillisinoprilCorePharma LLC
- Nov 13, 20359.2ypatentElixsure EXguaifenesinMoberg Pharma AB
- Dec 2, 20359.2ypatentArakodatafenoquine succinate$SXTP60 DEGREES PHARMACEUTICALS, INC.
- Jan 19, 20369.3ypatentTascenso ODTfingolimod [INN]Cycle Pharmaceuticals Ltd
- Feb 12, 20369.4ypatentRosuvastatin Calciumrosuvastatin calciumTeva Pharmaceuticals USA Inc
- Feb 16, 20369.4ypatentGvokeglucagon [INN]$XERSXeris Biopharma Holdings, Inc.
- Apr 21, 20369.6ypatentLansoprazolelansoprazoleNATCO Pharma Inc.
- Oct 11, 203610.1ypatentPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDEDEXTROMETHORPHAN HYDROBROMIDEHetero Labs Ltd
- Oct 28, 203610.1ypatentCarospirspironolactone [INN]CMP Pharma Inc
- Dec 8, 203610.2ypatentEsomeprazole Magnesiumesomeprazole magnesiumGuangzhou Novaken Pharmaceutical Co Ltd
- Dec 8, 203610.2ypatentPrilosecomeprazoleCovis Pharmaceuticals Inc (Inactive)
- Dec 19, 203610.3ypatentCevirahexaminolevulinate hydrochlorideAsieris Pharmaceuticals (USA) Inc
- Jan 9, 203710.3ypatentSaxendaliraglutideNovo Nordisk Inc
- Feb 3, 203710.4ypatentRelexxiimethylphenidate hydrochlorideVertical Pharmaceuticals LLC
- Feb 7, 203710.4ypatentNumbrinococaine hydrochlorideCody Laboratories Inc
- Mar 7, 203710.5ypatentRedemploplozasiran sodium$ARWRARROWHEAD PHARMACEUTICALS, INC.
- Apr 13, 203710.6ypatentDuloxetine Hydrochlorideduloxetine hydrochlorideQingdao Baheal Medical Inc
- May 12, 203710.7ypatentPizensylactitol [INN]Sebela Pharmaceuticals Inc
- May 31, 203710.7ypatentThiotepathiotepa [INN]STI Pharma LLC
- Jun 7, 203710.7ypatentAtorvaliqatorvastatin calciumCMP Pharma Inc
- Jul 25, 203710.9ypatentCalcium Gluconatecalcium gluconateWG Critical Care LLC
- Sep 8, 203711.0ypatentBACLOFENBACLOFENBeximco Pharmaceuticals USA Inc
- Dec 15, 203711.3ypatentMICAFUNGIN SODIUMMICAFUNGIN SODIUMXellia Pharmaceuticals USA LLC
- Jan 24, 203811.4ypatentRanolazineranolazineLaurus Generics Inc
- Apr 16, 203811.6ypatentNimodipinenimodipine$GRCEGrace Therapeutics, Inc.
- Jun 18, 203811.8ypatentMestinonpyridostigmine bromideBausch Health US LLC
- Jul 10, 203811.8ypatentZurnainalmefenePurdue Pharma LP
- Aug 18, 203811.9ypatentZonisamidezonisamideGranules Pharma LLC
- Aug 22, 203811.9ypatentTretinoin MylantretinoinMylan Pharmaceuticals Inc
- Sep 15, 203812.0ypatentIheezochloroprocaine [INN]$HROWHARROW, INC.
- Oct 25, 203812.1ypatentPrevduo(glycopyrrolate + neostigmine methylsulfate)Par Pharmaceutical Inc
- Nov 5, 203812.1ypatentAlvaizeltrombopag [INN]Teva Pharmaceuticals USA Inc
- Nov 14, 203812.2ypatentThiolatiopronin [INN]Mission Pharmacal Co
- Nov 23, 203812.2ypatentCLADRIBINECLADRIBINEEMD Serono Inc
- Dec 24, 203812.3ypatentChewtadzytadalafil$ANIPANI PHARMACEUTICALS INC
- Jan 11, 203912.3ypatentFosaprepitant Dimegluminefosaprepitant dimeglumineAthenex Inc (Inactive)
- Feb 1, 203912.4ypatentAnnovera(ethinylestradiol [INN] + segesterone acetate)Mayne Pharma USA Inc
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)